Assessment of knowledge on proper use of antibiotics, adherence and it’s resistance in in-patients and out-patients-A cross sectional study.
Abstract
INTRODUCTION: Antibiotics are very important to treat bacterial infections. Antibiotic resistance has been the greatest threat to modern medicine to indiscriminate and irrational use of antibiotics. This study involves understanding the knowledge, attitude, and practices of the community towards understanding antibiotic resistance.
AIM AND OBJECTIVES: The main aim of this study was to analyse patient’s knowledge regarding antibiotic use and educate them for proper use of antibiotics and to decrease resistance. The objectives are to assess the knowledge regarding antibiotics in patients, to provide correct information on antibiotics, to educate the patients regarding compliance and rational use of antibiotics, to educate patients regarding antibiotic resistance.
METHODOLOGY: This is an observational-cross sectional study.
RESULTS: The statistical analysis of this subject proved the level of significance (p value-<0.001) thus null hypothesis was rejected.
CONCLUSION: Antibiotics are life-saving medications for bacterial infections. Non-compliance and irrational use of antibiotics result in therapeutic failure, re-infection and bacterial resistance. Proper knowledge, attitude and practice is required to overcome resistance. Adherence to the medication is key factor in overcoming antibiotic resistance. Hence, education must be provided to the community regarding proper and rational use of antibiotics to overcome misuse, overuse, irrational use, self-medication habits and non-compliance to overcome antibiotic resistance. Antibiotic resistance can be avoided by implementing anti-microbial stewardship programme.
References
2. Rehman, M.T.; Faheem, M.; Khan, A.U. An insight into the biophysical characterization of different states of cefotaxime hydrolyzing β-lactamase 15 (CTX-M-15). J. Biomol. Struct. Dyn. 2015, 33, 625–638. [CrossRef] [PubMed]
3. Livermore, D.M. Bacterial Resistance: Origins, Epidemiology, and Impact. Clin. Infect. Dis. 2003, 36, S11–S23. [CrossRef] [PubMed]
4. Muteeb, G.; Alsultan, A.; Farhan, M.; Aatif, M. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Molecules 2022, 27, 1283. [CrossRef]
5. Khan, A.U.; Rehman, M.T. Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1. Antimicrob. Agents Chemother. 2016, 60, 356–360. [CrossRef] [PubMed]
6. Gould, K. Antibiotics: From prehistory to the present day. J. Antimicrob. Chemother. 2016, 71, 572–575. [CrossRef]
7. Clardy, J.; Fischbach, M.A.; Currie, C.R. The natural history of antibiotics. Curr. Biol. 2009, 19, R437–R441. [CrossRef]
8. Fleming, A. On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzæ. Br. J. Exp. Pathol. 1929, 10, 226–236. [CrossRef]
9. Hodgkin, D.C. The X-ray analysis of the structure of penicillin. Adv. Sci. 1949, 6, 85–89.
10. Sheehan, J.C.; Henery-Logan, K.R. The Total Synthesis of Penicillin, V.J. Am. Chem. Soc. 1959, 81, 3089–3094. [CrossRef]
11. Von Döhren, H. Antibiotics: Actions, Origins, Resistance, by C. Walsh. 2003; ASM Press: Washington, DC, USA, 2009; Volume 13, p. 345.
12. Abraham, E.P.; Chain, E. An Enzyme from Bacteria able to Destroy Penicillin. Nature 1940, 146, 837. [CrossRef]
13. Aminov, R.I. A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future. Front. Microbiol. 2010, 1, 134. [CrossRef] [PubMed]
14. Durand, G.A.; Raoult, D.; Dubourg, G. Antibiotic discovery: History, methods and perspectives. Int. J. Antimicrob. Agents 2019, 53, 371–382. [CrossRef] [PubMed]
15. Iskandar, K.; Murugaiyan, J.; Hammoudi Halat, D.; Hage, S.E.; Chibabhai, V.; Adukkadukkam, S.; Roques, C.; Molinier, L.; Salameh, P.; Van Dongen, M. Antibiotic Discovery and Resistance: The Chase and the Race. Antibiotics 2022, 11, 182. [CrossRef] [PubMed]
16. Christensen, S.B. Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and β-Lactams. Molecules 2021, 26, 6057. [CrossRef]
17. Chait, R.; Vetsigian, K.; Kishony, R. What counters antibiotic resistance in nature? Nat. Chem. Biol. 2012, 8, 2–5. [CrossRef]
18. Blair, J.M.A.; Webber, M.A.; Baylay, A.J.; Ogbolu, D.O.; Piddock, L.J.V. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13, 42–51. [CrossRef] [PubMed]
19. Livermore, D.M.; Blaser, M.; Carrs, O.; Cassell, G.; Fishman, N.; Guidos, R.; Levy, S.; Powers, J.; Norrby, R.; Tillotson, G.; et al. Discovery research: The scientific challenge of finding new antibiotics. J. Antimicrob. Chemother. 2011, 66, 1941–1944. [CrossRef]
20. Saga, T.; Yamaguchi, K. History of antimicrobial agents and resistant bacteria. Japan Med. Assoc. J. 2009, 52, 103–108.
